| ViiV Healthcare GmbH - Kivexa, Filmtabletten | | 56977 | | 01 | | Kivexa | | Filmtabletten | | J05AR02 | | Lamivudine and Abacavir | | 31.10.2005 | | |
| | Composition | | abacavirum 600 mg ut abacaviri sulfas, lamivudinum 300 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, magnesii stearas, Überzug: hypromellosum, macrogolum 400, polysorbatum 80, E 110 1.7 mg, E 171, pro compresso obducto corresp. natrium 2.31 mg. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Abacavir | 600 mg | | Lamivudine | 300 mg |
| | BAG: Active Agent | Dose |
|---|
| Abacavir | 600 mg | | Lamivudine | 300 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 110 | 1.7 mg | color. | | E 171 | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Magnesii Stearas | | | | Polysorbatum 80 | | | | Pro Compresso Obducto | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 30 Tablet(s) | 273.20 | 312.00 | A | SL | Yes |
|
|
